Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services/Psychosocial Research

Periodontal Disease and Mortality in Type 2 Diabetes

  1. Aramesh Saremi, MD1,
  2. Robert G. Nelson, MD, PHD1,
  3. Marshall Tulloch-Reid, MB, BS, DSC1,
  4. Robert L. Hanson, MD, MPH1,
  5. Maurice L. Sievers, MD1,
  6. George W. Taylor, DMD, DRPH2,
  7. Marc Shlossman, DDS, MS3,
  8. Peter H. Bennett, MB, FRCP1,
  9. Robert Genco, DDS, PHD3 and
  10. William C. Knowler, MD, DRPH1
  1. 1National Institute of Diabetes and Digestive and Kidney Disease, Phoenix, Arizona
  2. 2University of Michigan School of Dentistry, Ann Arbor, Michigan
  3. 3University at Buffalo, Buffalo, New York
  1. Address correspondence to Robert G. Nelson, MD, PhD, 1550 E. Indian School Rd., Phoenix, AZ 85014. E-mail: rgnelson{at}mail.nih.gov
Diabetes Care 2005 Jan; 28(1): 27-32. https://doi.org/10.2337/diacare.28.1.27
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE—Periodontal disease may contribute to the increased mortality associated with diabetes.

RESEARCH DESIGN AND METHODS—In a prospective longitudinal study of 628 subjects aged ≥35 years, we examined the effect of periodontal disease on overall and cardiovascular disease mortality in Pima Indians with type 2 diabetes. Periodontal abnormality was classified as no or mild, moderate, and severe, based on panoramic radiographs and clinical dental examinations.

RESULTS—During a median follow-up of 11 years (range 0.3–16), 204 subjects died. The age- and sex-adjusted death rates for all natural causes expressed as the number of deaths per 1,000 person-years of follow-up were 3.7 (95% CI 0.7–6.6) for no or mild periodontal disease, 19.6 (10.7–28.5) for moderate periodontal disease, and 28.4 (22.3–34.6) for severe periodontal disease. Periodontal disease predicted deaths from ischemic heart disease (IHD) (P trend = 0.04) and diabetic nephropathy (P trend < 0.01). Death rates from other causes were not associated with periodontal disease. After adjustment for age, sex, duration of diabetes, HbA1c, macroalbuminuria, BMI, serum cholesterol concentration, hypertension, electrocardiographic abnormalities, and current smoking in a proportional hazards model, subjects with severe periodontal disease had 3.2 times the risk (95% CI 1.1–9.3) of cardiorenal mortality (IHD and diabetic nephropathy combined) compared with the reference group (no or mild periodontal disease and moderate periodontal disease combined).

CONCLUSIONS— Periodontal disease is a strong predictor of mortality from IHD and diabetic nephropathy in Pima Indians with type 2 diabetes. The effect of periodontal disease is in addition to the effects of traditional risk factors for these diseases.

  • CVD, cardiovascular disease
  • ECG, electrocardiogram
  • IHD, ischemic heart disease
  • PAF, population attributable fraction

Periodontal disease, a common chronic oral inflammatory disease, is characterized by destruction of soft tissue and bone. Modulation of host factors, such as diabetes, is important for the progression or worsening of periodontal disease (1,2). Although the pathogenesis of periodontal disease in diabetes remains unclear, most evidence suggests that it may result from prolonged exposure to hyperglycemia and occurs with the greatest frequency and severity in those with poor glycemic control (3–5). Several epidemiological studies suggest that periodontal infection may be a risk factor for heart disease (reviewed in 6). Diabetic persons with severe periodontal disease may be particularly susceptible to microvascular and macrovascular complications, which are primarily responsible for the increased morbidity and mortality associated with diabetes. To our knowledge, no previous studies have investigated the risk of cardiovascular disease (CVD) mortality associated with periodontal disease in patients with diabetes.

The aim of this study was to examine the effect of periodontal disease on overall and CVD mortality in Pima Indians with type 2 diabetes, after accounting for the impact of common risk factors for both diseases.

RESEARCH DESIGN AND METHODS

Population study and medical examination

Residents of the Gila River Indian Community of Arizona, most of whom are Pima or closely related Tohono O’odham Indians, participate in a longitudinal population-based study of diabetes and its complications conducted by the National Institute of Diabetes and Digestive and Kidney Diseases (7). Approximately every 2 years, each member of the community aged ≥5 years is invited to participate in a standardized examination (biennial examination) that includes a medical history, physical examination, and measurement of BMI, blood pressure, plasma glucose level, HbA1c level, serum cholesterol concentration, and albuminuria. HbA1c was measured until 31 December 1989 by agar gel electrophoresis (8), after which HbA1c was measured by high-performance liquid chromotomography (9).

Among 133 subjects (not from this study) in whom both variables were measured, the correlation between the two measures was 0.92. The linear regression formula from this comparison (HbA1c = 0.99 × HbA1c − 1.535) was used to estimate HbA1c in subjects in this study in whom HbA1c was measured (10). Subjects were considered hypertensive if their systolic blood pressure was ≥140 mmHg, their diastolic blood pressure was ≥90 mmHg, or they were taking antihypertensive drugs. Smoking was assessed by an interviewer-administered questionnaire. Current smoking was defined as cigarette smoking in any amount during the past year. Previous smokers who reported no smoking during the past year were included in the nonsmoking category. Twelve-lead electrocardiograms (ECGs) were recorded in all subjects during the first biennial examination and during each examination subsequent to the 15th birthday. All ECGs were interpreted and classified according to the Minnesota Code by the same cardiologist, who had no knowledge of the clinical data. Major ECG abnormalities were identified according to the Tecumseh criteria (11,12). Total serum cholesterol was measured by a colorimetric method (13). A urinary albumin-to-creatinine ratio (mg albumin/g creatinine) was used as an estimate of albumin excretion rate (14). Macroalbuminuria was defined as an albumin-to-creatinine ratio ≥300 mg/g. Diabetes was defined by 1985 World Health Organization criteria (15) if plasma glucose concentration was ≥200 mg/dl 2 h after a 75-g oral glucose load or if a clinical diagnosis was documented in the medical record.

Dental examination

Periodic dental examinations were conducted from January 1983 to September 1990 as part of the biennial research visits. Dentists performed the examinations without knowledge of the patient’s medical status. Each examination included an evaluation of the oral mucous membranes by visual and digital examination of six index teeth or their substitutes (16) and an evaluation of alveolar bone loss score from a panoramic radiograph of all existing teeth (OP-5; Siemens, Munich, Germany). Probing attachment levels were measured at four sites: midbuccal, midlingual, mesial interproximal point, and distal interproximal point. The median probing attachment loss at 24 sites (four sites on each of six index teeth) and median alveolar bone loss scores among all teeth were used as two measures of the presence and severity of periodontal disease. For these analyses, a missing tooth was assigned a value higher than the maximum recorded measurements so that edentulous patients or patients with missing index teeth could be included. A total of 72% of the extractions in this population were due to periodontal disease (1). Periodontal disease was classified as no or mild, moderate, and severe. Individuals with no or mild periodontal disease had 15 or more teeth, a median bone loss score <50%, and median attachment loss of <1 mm. Individuals with moderate periodontal disease had 15 or more teeth, a median bone loss score of 50–75%, or a median attachment loss of 2–5 mm. Those with severe periodontal disease had less than 15 teeth or a median bone loss score of >75% or a median attachment loss of ≥6 mm. A more detailed description of the dental examination is provided elsewhere (1).

Of a total of 772 diabetic individuals aged ≥35 years who lived in Gila River Indian community at any time between 1 January 1983 and 30 September 1990, whose heritage was at least 50% Pima or Tohono O’odham, 144 subjects (19%) were excluded from a particular examination for various reasons, including patient refusal (no radiograph and/or probing), pregnancy (no radiograph), heart conditions requiring antibiotic prophylaxis (no probing), mixed dentition (no bone loss score), equipment failure (no radiograph), inability to position patient (no radiograph), or no clinical examination (no probing).

The study population consisted of 628 diabetic individuals who had undergone at least one dental examination with both radiographic bone scores and clinical assessment of attachment levels.

Assessment of vital status

Vital status of all subjects was ascertained as of December 1998. For all deaths, the underlying and contributing causes were assessed by review of clinical reports and reports of autopsy, medical examiner findings, and death certificates (17). The adjudicated causes were coded using terminology and codes of the ICD-9 in accordance with the guidelines of the National Center for Health Statistics. Deaths were considered “natural” if they were due to disease (ICD-9 codes 001.0–799.9) and “external” if they were due to injury or poisoning (ICD-9 codes E800.0-E999.9). The codes for other causes are given in Table 1. Death rates due to ischemic heart disease (IHD) and diabetic nephropathy were analyzed together as a category of cardiorenal disease.

Statistical analysis

Death rates were calculated as the number of deaths per 1,000 person-years of follow-up after the age of 35 years. The period of risk extended from the initial dental examination to death or December 1998. When subjects were reexamined and the periodontal classification changed, the new values were used for subsequent follow-up. Death rates were age- and sex-adjusted to the 1985 Pima Indian population.

The effect of periodontal disease on mortality was examined using a time-dependent Cox proportional hazards model to control for the effect of potentially confounding variables. If the values of variables changed at reexamination, the new values were included for the subsequent times. For this analysis, severe periodontal disease was compared with the reference group of no or mild and moderate periodontal disease combined. To allow for the nonlinear effects of BMI on mortality (18), a quadratic term was used to adjust for BMI in the Cox proportional hazards models. To assess the possibility of effect modification, pairwise interaction terms between periodontal disease and sex, age, duration of diabetes, and smoking were evaluated.

The age- and sex-adjusted population attributable fraction (PAF) was calculated by the weighted-sum method (19). Math where PAFj represents population attributable risk for the jth stratum of age and sex and wj represents the number of deaths observed in the jth stratum divided by the total number of deaths. This method of calculating attributable fraction controls for confounding by age and sex.

RESULTS

Clinical and demographic features of the study population at the baseline examination are shown in Table 2. Nearly 60% of the population (373) had severe periodontal disease, and 70% (263) of those with severe periodontal disease were edentulous. In general, individuals with severe periodontal disease were older and had longer duration of diabetes, higher fasting glucose level, HbA1c level, total cholesterol concentration, and higher prevalence of macroalbuminuria, hypertension, and ECG abnormalities. Individuals with severe periodontal disease had lower BMI and lower smoking rates than those with no or mild or moderate periodontal disease.

During follow-up, which averaged 11 years (range 0.3–16), 204 of the 628 study subjects died (Table 2). Most CVD deaths (44 of 54) were attributed to IHD, and most of the diabetes-related deaths (28 of 35) were attributed to diabetic nephropathy. Other CVD deaths and other diabetes-related deaths were not significantly associated with periodontal disease. IHD and diabetic nephropathy deaths combined (cardiorenal, n = 72) were the leading underlying cause of death in both sexes (death rate: 8.8/1,000 person-years in men, 8.0/1,000 person-years in women). The age-sex–adjusted death rate per 1,000 person-years for IHD was 0 among subjects with no or mild periodontal disease, 4.8 (95% CI 0.5–9.1) among those with moderate periodontal disease, and 5.7 (3.6–7.7) among people with severe periodontal disease (P trend = 0.04). The death rates per 1,000 person-years for diabetic nephropathy (n = 28) were 0 among those with no or mild periodontal disease, 0.5 (0.4–1.3) in individuals with moderate periodontal disease, and 5.3 (2.0–8.5) among those with severe periodontal disease (P trend < 0.01).

The age-sex–adjusted death rate for all natural causes of death was also significantly lower in individuals with no or mild periodontal disease (3.7 [0.7–6.6]) compared with moderate periodontal disease (19.6 [10.7–28.5]) and severe periodontal disease (28.4 [22.3–34.6]) (P trend < 0.01). After exclusion of cardiorenal deaths, the rates were 3.7 (0.7–6.6) for no or mild periodontal disease, 14.4 (16.6–22.1) for moderate periodontal disease, and 17.5 (12.7–22.3) for severe periodontal disease (Fig. 1), and the positive trend was weaker (P = 0.05).

In subjects with severe periodontal disease, the death rate from IHD was 2.3 (0.9–5.8) times as high and the death rate from diabetic nephropathy was 8.5 (1.1–65.0) times as high as in those with less severe periodontal disease (no or mild and moderate periodontal disease combined), after adjustment for age, sex, and duration of diabetes in a Cox proportional hazards model. Among those who died of IHD, 55% (24 of 44) had advanced diabetic kidney disease; 4 patients had elevated serum creatinine concentrations (≥2.0 mg/dl), and 20 patients were receiving renal replacement therapy. When both renal and CVD (cardiorenal) deaths were analyzed, the death rate from cardiorenal disease in subjects with severe periodontal disease was 3.5 (1.2–10.0) times as high as in those with less severe periodontal disease after adjustment for age, sex, duration of diabetes, BMI, hypertension, fasting plasma glucose concentration, serum cholesterol concentration, ECG abnormalities, macroalbuminuria, and current smoking behavior (Table 3). The results were similar when HbA1c was substituted for fasting plasma glucose concentration in the proportional hazards model (data not shown).

The interaction term between periodontal disease and age was significant in predicting cardiorenal deaths (P = 0.01); therefore, the hazard rate ratios were examined by age-groups. Adjusted for sex, the hazard rate ratio for periodontal disease was 14.8 (3.5–63.2) in the age-group 35–54 years and 3.3 (0.8–14.0) in the age-group ≥55 years. Accordingly, as shown in Table 4, the fraction of cardiorenal deaths attributable to exposure to severe periodontal disease was higher in younger age-groups. The age- and sex-adjusted fraction of cardiorenal deaths attributable to exposure to severe periodontal disease was 57%. Other interaction terms between periodontal disease and sex, duration of diabetes, and smoking were not statistically significant. Such terms, therefore, were not included in the final models.

CONCLUSIONS

Death rates from IHD and nephropathy were higher in diabetic Pima Indians with severe periodontal disease than in those with no or mild periodontal disease or moderate periodontal disease. Death rates from other causes were less affected by the presence of severe periodontal disease. The fact that both IHD and diabetic nephropathy were affected is not surprising, because they share many of the same risk factors. Patients undergoing hemodialysis and others with chronic kidney disease face a greatly increased risk of atherosclerotic complications, including myocardial infarction, cerebrovascular accidents, and sudden death due to cardiac arrhythmia (20). Furthermore, among diabetic Pima Indians, death rates for IHD have increased in recent years, largely as a result of the wide availability of renal replacement therapy and the corresponding reduction in deaths from diabetic nephropathy (21). Therefore, the distinction between IHD and renal disease as a cause of death may be partly artifactual, because they are closely competing causes of death. Accordingly, we combined IHD and diabetic nephropathy deaths into one category of cardiorenal deaths.

Other risk factors for cardiorenal disease, such as older age, longer duration of diabetes, poor glycemic control, higher serum cholesterol concentration, and higher prevalence of macroalbuminuria and hypertension, are also found more frequently in patients with severe periodontal disease and may contribute to the higher death rate from cardiorenal disease. Poor glycemic control, in particular, is a widely recognized risk factor for the macrovascular (CVD) and microvascular (retinopathy, nephropathy, and neuropathy) complications of diabetes, and previous studies have found an association between poor glycemic control and poor periodontal health (3–5). Nevertheless, in the present study, the association between periodontal disease and cardiorenal deaths remained significant after adjustment for glycemic control, measured either by fasting glucose concentration or by HbA1c. In addition to these risk factors, diabetic Pima Indians with severe periodontal disease had lower BMI, which may reflect underlying illness because it is associated with higher mortality rates in this population (18).

Heavy smoking is strongly associated with both periodontal disease and CVD (22) and undoubtedly confounds the relationship between these diseases (23–28). In the present study, however, smoking was not associated with periodontal disease. Of the subjects in this study, >60% reported never smoking, and heavy smoking (more than one pack a day) was reported by <1%. As shown in previous studies, the prevalence of heavy smoking is low in Pima Indians (29), and smoking is not a major significant risk factor for coronary heart disease in this population (30). Analyses of smoking using different groupings of current, never, and past smokers gave similar results to those presented here. Smoking did not predict cardiorenal mortality in this study, and severe periodontal disease remained a strong and significant predictor of cardiorenal deaths in both smokers and nonsmokers.

Most individuals with severe periodontal disease were edentulous, and 72% of tooth extractions in this population were due to periodontal disease (1). Misclassification in the severe periodontal disease group could occur, to the extent that edentulous subjects were edentulous for reasons other than periodontal disease. Nevertheless, exclusion of edentulous subjects did not substantially change the effect estimates (data not shown). Subjects with teeth and severe periodontal disease continued to have the highest cardiorenal mortality rates, suggesting that the extent of this misclassification was small.

The prevalence of periodontal disease is high in Pima Indians, even before the onset of diabetes (1,2); diabetes further increases the risk of periodontal disease (1–3,31). Diabetes is a strong, independent risk factor for CVD, and it is noteworthy that the death rate from cardiorenal diseases among diabetic subjects with no or mild periodontal disease was 0. The death rate from cardiorenal disease did increase significantly, however, with increasing severity of periodontal disease (P trend < 0.01). On the other hand, periodontal disease and CVD have many common risk factors, which could lead to a noncausal association. Common risk factors include diabetes, age, smoking, health behaviors and habits, socioeconomic status, diet, and access to care (32). Nevertheless, in this study of individuals with diabetes, the relationship between periodontal disease and CVD remained significant after accounting for many of these shared risk factors. However, we cannot exclude the potential for confounding by unmeasured risk factors. Socioeconomic status, which may influence health care, was not evaluated in this study. There was also no estimate of diet. However, the extent to which socioeconomic status influences access to health care in this population may be less than in other populations, because medical and dental care is provided to all community members at no cost.

Of the study population, ∼19% of subjects were excluded from the analysis due to missing values. Nevertheless, the mortality rates for cardiorenal deaths and all other causes of death for the excluded 19% were not significantly different from the rest of the population included in this study.

The association between periodontal disease and CVD has been reviewed extensively (33). Inflammation associated with periodontal disease may play a central role in the pathogenesis of CVD (34). As with other chronic infections, chronic periodontal disease is associated with systemic changes in blood and blood-forming organs, which may result in activation of markers of inflammation and acute-phase proteins such as C-reactive protein (34). Studies of periodontal disease and CVD or of diabetes and CVD that focus on inflammation are limited by the nonspecific nature of existing markers and the inability of most studies to distinguish acute inflammation from chronic low-grade inflammation. However, despite these limitations, there is remarkable consistency in the findings from a number of studies on the relationship between markers of inflammation, abnormalities of glucose metabolism, and CVD (35). Studies of diabetes and CVD suggest that low-level, chronic inflammation is associated with endothelial dysfunction (35), a pathway potentially linking diabetes and periodontal disease to CVD.

In summary, periodontal disease is a major public health burden in Pima Indians, and it is a strong predictor of death from cardiorenal disease in those with type 2 diabetes. Most cardiorenal deaths were attributable to periodontal disease exposure, and this proportion was remarkably high in younger age-groups. The effect of periodontal disease is in addition to the effects of traditional risk factors for these diseases. Whether prevention or treatment of periodontal disease can reduce the death rate from either disease, however, remains to be determined.

Figure 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1—

Mortality rates for all natural causes by periodontal disease (adjusted for age and sex to the 1985 Pima Indian population). □, cardiorenal deaths; ▪, all other natural deaths.

View this table:
  • View inline
  • View popup
Table 1—

Number of deaths and death rates in diabetic Pima Indians by periodontal disease

View this table:
  • View inline
  • View popup
Table 2—

Baseline characteristics of 628 diabetic individuals

View this table:
  • View inline
  • View popup
Table 3—

Estimated effect (death rate ratio and 95% CI) of periodontal disease and other factors on deaths from cardiorenal disease

View this table:
  • View inline
  • View popup
Table 4—

Estimation of weighted-sum population attributable fraction

Acknowledgments

This study was supported in part by USPHS Grant DE-06514 from the National Institute of Dental Research.

We thank the members of the Gila River Indian Community for participation in this investigation. We also thank the physicians and technical staff of the Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive Kidney Diseases, for conducting the diabetes examinations and processing the diabetes data.

Footnotes

  • M.S. is currently in practice in Chandler, Arizona.

    A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted September 19, 2004.
    • Received June 4, 2004.
  • DIABETES CARE

References

  1. ↵
    Shlossman M, Knowler WC, Pettitt DJ, Genco RJ: Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 121: 532–536, 1990
    OpenUrlAbstract
  2. ↵
    Nelson RG, Shlossman M, Budding LM, Pettitt DJ, Saad MF, Genco RJ, Knowler WC: Periodontal disease and NIDDM in Pima Indians. Diabetes Care 13:836–840, 1990
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, Pettitt DJ: Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 69:76–83, 1998
    OpenUrlPubMedWeb of Science
  4. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, Pettitt DJ: Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 67:1085–1093, 1996
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Tsai C, Hayes C, Taylor GW: Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Commun Dent Oral Epidemiol 30:182–192, 2002
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Genco R, Offenbacher S, Beck J: Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms. J Am Dent Assoc 133 (Suppl.):14S–22S, 2002
  7. ↵
    Knowler WC, Saad MF, Pettitt DJ, Nelson RG, Bennett PH: Determinants of diabetes mellitus in the Pima Indians. Diabetes Care 16:216–227,1993
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Menard L, Dempsey ME, Blankstein LA, Aleyassine H, Wacks M, Soeldner JS: Quantitiative determination of glycosylated hemoglobin A1 by agar gel electrophoresis. Clin Chem 26:1598–1602, 1980
    OpenUrlFREE Full Text
  9. ↵
    Ellis G, Diamandis EP, Giesbrecht EE, Daneman D, Allen LC: An automated “high-pressure” liquid-chromatographic assay for hemoglobin A1c. Clin Chem 30:1746–1752, 1984
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Nelson RG, Morgenstern H, Bennett PH: Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus. Am J Epidemiol 148:650–656, 1998
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, Liebow IM, Howard BV, Bennett PH: Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81:987–995, 1990
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Rose GA, Blackburn H: Cardiovascular survey methods. Monogr Ser World Health Organ 56:1–188, 1968
    OpenUrlPubMed
  13. ↵
    Block WD, Jarrett KJ Jr, Levine JB: An improved automated determination of serum total cholesterol with a single color reagent. Clin Chem 12:681–689, 1966
    OpenUrlAbstract
  14. ↵
    Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC: Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 32:870–876, 1989
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
  16. ↵
    Ramfjord SP: The periodontal disease index (PDI). J Periodontol 38 (Suppl. 10):602–610, 1967
    OpenUrl
  17. ↵
    Sievers ML, Nelson RG, Bennett PH: Adverse mortality experience of a southwestern American Indian community: overall death rates and underlying causes of death in Pima Indians. J Clin Epidemiol 43:1231–1242, 1990
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Hanson RL, McCance DR, Jacobsson LT, Narayan KM, Nelson RG, Pettitt DJ, Bennett PH, Knowler WC: The U-shaped association between body mass index and mortality: relationship with weight gain in a Native American population. J Clin Epidemiol 48:903–916, 1995
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    Benichou J: A review of adjusted estimators of attributable risk. Stat Methods Med Res 10:195–216, 2001
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Culleton BF, Hemmelgarn BR: Is chronic kidney disease a cardiovascular disease risk factor? Semin Dial 16:95–100, 2003
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    Pavkov ME, Sievers ML, Knowler WC, Bennett PH, Nelson RG: An explanation for the increase in heart disease mortality rates in diabetic Pima Indians: effect of renal replacement therapy. Diabetes Care 27:1132–1136, 2004
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Persson RE, Hollender LG, Powell VL, MacEntee M, Wyatt CC, Kiyak HA, Persson GR: Assessment of periodontal conditions and systemic disease in older subjects. II. Focus on cardiovascular diseases. J Clin Periodontol 29:803–810, 2002
    OpenUrlCrossRefPubMed
  23. ↵
    Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA: Periodontal disease and coronary heart disease risk. JAMA 284:1406–1410, 2000
    OpenUrlCrossRefPubMedWeb of Science
  24. Hujoel PP: Does chronic periodontitis cause coronary heart disease? A review of the literature. J Am Dent Assoc 133(Suppl.):31S–36S, 2002
  25. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA: Pre-existing cardiovascular disease and periodontitis: a follow-up study. J Dent Res 81:186–191, 2002
    OpenUrlAbstract/FREE Full Text
  26. Morrison HI, Ellison LF, Taylor GW: Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 6:7–11, 1999
    OpenUrlPubMedWeb of Science
  27. Howell TH, Ridker PM, Ajani UA, Hennekens CH, Christen WG: Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians. J Am Coll Cardiol 37:445–450, 2001
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    Joshipura KJ, Rimm EB, Douglass CW, Trichopoulos D, Ascherio A, Willett WC: Poor oral health and coronary heart disease. J Dent Res 75:1631–1636, 1996
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Sievers ML, Bennett PH, Roumain J, Nelson RG: Effect of hypertension on mortality in Pima Indians. Circulation 100:33–40, 1999
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK: Coronary heart disease prevalence and its relation to risk factors in American Indians: the Strong Heart Study. Am J Epidemiol 142:254–268, 1995
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Emrich LJ, Shlossman M, Genco RJ: Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 62:123–131, 1991
    OpenUrlPubMedWeb of Science
  32. ↵
    Joshipura K: The relationship between oral conditions and ischemic stroke and peripheral vascular disease. J Am Dent Assoc 133(Suppl.):23S–30S, 2002
  33. ↵
    Beck JD, Slade G, Offenbacher S: Oral disease, cardiovascular disease and systemic inflammation. Periodontol 23:110–120, 2000
  34. ↵
    Kinane DF, Lowe GD: How periodontal disease may contribute to cardiovascular disease. Periodontol 23:121–126, 2000
  35. ↵
    Resnick HE, Howard BV: Diabetes and cardiovascular disease. Annu Rev Med 53:245–267, 2002
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Diabetes Care: 28 (1)

In this Issue

January 2005, 28(1)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Periodontal Disease and Mortality in Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Periodontal Disease and Mortality in Type 2 Diabetes
Aramesh Saremi, Robert G. Nelson, Marshall Tulloch-Reid, Robert L. Hanson, Maurice L. Sievers, George W. Taylor, Marc Shlossman, Peter H. Bennett, Robert Genco, William C. Knowler
Diabetes Care Jan 2005, 28 (1) 27-32; DOI: 10.2337/diacare.28.1.27

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Periodontal Disease and Mortality in Type 2 Diabetes
Aramesh Saremi, Robert G. Nelson, Marshall Tulloch-Reid, Robert L. Hanson, Maurice L. Sievers, George W. Taylor, Marc Shlossman, Peter H. Bennett, Robert Genco, William C. Knowler
Diabetes Care Jan 2005, 28 (1) 27-32; DOI: 10.2337/diacare.28.1.27
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes
  • Disparities in Diabetes Care Between Smokers and Nonsmokers
  • Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes
Show more Epidemiology/Health Services/Psychosocial Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.